The GP IIb/IIIa inhibitor abciximab (c7E3) inhibits the binding of various ligands to the leukocyte integrin Mac-1 (CD11b/CD18, αMβ2)
- 15 August 2002
- journal article
- Published by Elsevier in Thrombosis Research
- Vol. 107 (3-4) , 121-128
- https://doi.org/10.1016/s0049-3848(02)00207-4
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Integrin StructureBiochemical Society Transactions, 2000
- IIb’s are not IIb’sThe American Journal of Cardiology, 2000
- Multiple Discontinuous Ligand-mimetic Antibody Binding Sites Define a Ligand Binding Pocket in Integrin αIIbβ3Journal of Biological Chemistry, 2000
- Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".Journal of Clinical Investigation, 1996
- Overlapping, but Not Identical, Sites Are Involved in the Recognition of C3bi, Neutrophil Inhibitory Factor, and Adhesive Ligands by the αMβ2 IntegrinJournal of Biological Chemistry, 1996
- Novel antiplatelet therapies for treatment of patients with ischemic heart disease: Inhibitors of the platelet glycoprotein IIbIIIa integrin receptorAmerican Heart Journal, 1995
- Neutrophil activation after percutaneous transluminal coronary angioplastyAmerican Heart Journal, 1994
- Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigmCell, 1994
- Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion.Journal of Clinical Investigation, 1991
- Oligospecificity of the cellular adhesion receptor Mac-1 encompasses an inducible recognition specificity for fibrinogen.The Journal of cell biology, 1988